Explore Stanford technologies available for licensing:

Introduction: Blood cell transfusion plays a vital role in modern medicine–supporting surgery, obstetrics, trauma care, and cancer chemotherapy. In the US alone, more than 12 million red-cell units are consumed annually.

Non-alcoholic steatohepatitis (NASH) is the most common liver disease, leading to cirrhosis and hepatocellular carcinoma (HCC). HCC is one of the most common cancers and has a dismal prognosis as currently available medical treatment only improves survival by a few months.

Stanford researchers within the Cui Lab have discovered a promising practical application for grid-scale energy storage by solving poor electronic conductivity in Mn based aqueous batteries, resulting in cycling with an ultrahigh areal loading of 20 mAh cm-2 for over 200 cy

Stanford researchers at the Woo Lab have designed and manufactured a flexible, compact laparoscopic device for knot tying during cardiac, thoracic, and ENT operations.

Stanford scientists have discovered that a subset of human cathepsins can degrade cancer-associated mucins.

Stanford researchers have created a system that enables efficient fabrication of complex three-dimensional (3D) nanostructures via triplet-triplet-annihilation upconversion (TTA-UC).

Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring.

Researchers in the Murmann Mixed Signal Group have developed a pipelined chip architecture with inverted residual and linear bottlenecks-based networks for energy efficient Machine Learning inference on edge devices.

Technology Reference: Chan Zuckerberg CZB-190S; Stanford S20-449

Summary
Researchers at Stanford have developed a method enabling quantification of intracellular protein levels using oligonucleotide-barcoded antibodies.

Stanford scientists have created software, referred to as Symbolica, for automating model development for multiscale systems that can accelerate the generation of multi-physical models by 10^5 times what can be completed by hand.

Researchers at Stanford University have developed a method which integrates cell barcoding and high-throughput sequencing to quantify tumor growth in genetically engineered mouse models of human cancer (called 'Tuba-seq” for Tumor barcoding coupled with seq

Researchers at Stanford have identified GPR84 as a new highly specific imaging biomarker of neuroinflammation and innate immune activation.

Stanford scientists have invented protein degraders that induce lysosomal degradation of extracellular cargo.

Researchers at Stanford have proposed that coating surgical sutures with mechanotransduction inhibitors may reduce scarring of the tissue.

Stanford researchers have developed a cost effective replacement for bipolar membrane (BPM) electrodialysis, called bipolar electrode (BPE) that more efficiently splits water into separate streams of protons and hydroxide ions.